Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
11 results
  1. NLM Digital Collections - Management of stable angina : a national clinical guideline 
    Publication: Edinburgh, Scotland : SIGN, 2007
    resource.nlm.nih.gov/101300496
    ... eluting stents). Several RCTs have shown that both sirolimus and paclitaxel coated stents reduce the need for ... revascularisation or major cardiac event rates between 1++ sirolimus and paclitaxel coated stents.95 Coated stents delay ...
  2. NLM Digital Collections - Management of stable angina : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), April 2018
    resource.nlm.nih.gov/101730371
    ... using first generation DES have shown that both sirolimus and paclitaxel coated + 1 stents reduce the need ... 12 trials used DES (FREEDOM - first-generation; CARDia - sirolimus in 69% of patients, BMS in 21%) and ...
  3. NLM Digital Collections - Management of primary cutaneous squamous cell carcinoma : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), June 2014
    resource.nlm.nih.gov/101671126
    ... of SCC maintained on ciclosporin or converted to sirolimus-based immunosuppression, a significantly longer SCC-free survival was demonstrated in the sirolimus 2+ group (15 v 7 months p=0. ...
  4. NLM Digital Collections - Epilepsies in children and young people : investigative procedures and management : a ... 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), May 2021
    resource.nlm.nih.gov/9918334378406676
    ... 4++ L ++ | 1++ One underpowered RCT reported that sirolimus did not significantly reduce seizure frequency Ie in ... 24 There is insufficient evidence to indicate using sirolimus to treat refractory seizures in children with TSC. ...
  5. NLM Digital Collections - Medicare Part B drug payments : impact of price substitutions based on 2015 average sales ... 
    Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2017
    resource.nlm.nih.gov/101737976
    ... 279 J3415 Pyridoxine HCl injection  $10,620 J7520 Sirolimus oral    $5,270,778 J9178 Epirubicin HCl injection  $ ...
  6. NLM Digital Collections - Medicare Part B drug payments : impact of price substitutions based on 2016 average sales ... 
    Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2018
    resource.nlm.nih.gov/101738128
    ... 477 J2700 Oxacillin sodium injection  $3,678 J7520 Sirolimus oral     $5,967,216 J9178 Epirubicin HCl injection   $ ...
  7. NLM Digital Collections - Medicare Part B drug payments : impact of price substitutions based on 2017 average sales ... 
    Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2019
    resource.nlm.nih.gov/101757611
    ... 1,867,572 J3486 Ziprasidone mesylate  $13 J7520 Sirolimus oral     $5,110,869 J9100 Cytarabine HCl injection  $ ...
  8. NLM Digital Collections - Breast implants : certain labeling recommendations to improve patient communication : ... 
    Publication: [Silver Spring, MD] : Center for Devices and Radiological Health, September 29, 2020
    resource.nlm.nih.gov/9918232103006676
    ... steroids and chemotherapy drugs (e.g., prednisone, tacrolimus, sirolimus, mycophenolate, azathioprine, cyclosporine, methotrexate, chlorambucil, leflunomide, or cyclophosphamide); • ...
  9. NLM Digital Collections - Medicare Part B drug payments : impact of price substitutions based on 2018 average sales ... 
    Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2020
    resource.nlm.nih.gov/9918282381206676
    ... sulfate injection    $400 J3486 Ziprasidone mesylate     $30 J7520 Sirolimus oral     $3,304,957 J9100 Cytarabine HCl injection     $ ...
  10. NLM Digital Collections - Medicare Part B drug payments : impact of price substitutions based on 2019 average sales ... 
    Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2021
    resource.nlm.nih.gov/9918383970106676
    ... HCl   $145,755 J3486a Ziprasidone mesylate     $0 J7520 Sirolimus oral    $2,776,401 J9100 Cytarabine HCl injection    $ ...
previous · 1 · 2 · next